Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
AIDS. 2010 Jan 16;24(2):195-204. doi: 10.1097/QAD.0b013e3283353bba.
In the absence of HIV-1 virion infectivity factor (Vif), cellular cytosine deaminases such as apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) inhibit the virus by inducing hypermutations on viral DNA, among other mechanisms of action. We investigated the association of APOBEC3G mRNA levels and genetic variants on HIV-1 susceptibility, and early disease pathogenesis using viral load and CD4 T-cell counts as outcomes.
Study participants were 250 South African women at high risk for HIV-1 subtype C infection. We used real-time PCR to measure the expression of APOBEC3G in HIV-negative and HIV-positive primary infection samples. APOBEC3G variants were identified by DNA re-sequencing and TaqMan genotyping.
We found no correlation between APOBEC3G expression levels and plasma viral loads (r = 0.053, P = 0.596) or CD4 T-cell counts (r = 0.030, P = 0.762) in 32 seroconverters. APOBEC3G expression levels were higher in HIV-negative individuals as compared with HIV-positive individuals (P < 0.0001), including matched pre and postinfection samples from the same individuals (n = 13, P < 0.0001). Twenty-four single nucleotide polymorphisms, including eight novel, were identified within APOBEC3G by re-sequencing and genotyping. The H186R mutation, a codon-changing variant in exon 4, and a 3' extragenic mutation (rs35228531) were associated with high viral loads (P = 0.0097 and P < 0.0001) and decreased CD4 T-cell levels (P = 0.0081 and P < 0.0001), respectively.
These data suggest that APOBEC3G transcription is rapidly downregulated upon HIV-1 infection. During primary infection, APOBEC3G expression levels in peripheral blood mononuclear cells do not correlate with viral loads or CD4 T-cell counts. Genetic variation of APOBEC3G may significantly affect early HIV-1 pathogenesis, although the mechanism remains unclear and warrants further investigation.
在缺乏 HIV-1 病毒感染力因子(Vif)的情况下,细胞胞嘧啶脱氨酶,如载脂蛋白 B mRNA 编辑酶催化多肽样 3G(APOBEC3G),通过在病毒 DNA 上诱导高突变等作用机制来抑制病毒。我们研究了 APOBEC3G mRNA 水平和遗传变异与 HIV-1 易感性和早期疾病发病机制的相关性,使用病毒载量和 CD4 T 细胞计数作为结果。
研究参与者为 250 名南非高危感染 HIV-1 亚型 C 的女性。我们使用实时 PCR 测量 HIV-阴性和 HIV-阳性原发性感染样本中 APOBEC3G 的表达。通过 DNA 重测序和 TaqMan 基因分型鉴定 APOBEC3G 变体。
在 32 名血清转化者中,我们未发现 APOBEC3G 表达水平与血浆病毒载量(r = 0.053,P = 0.596)或 CD4 T 细胞计数(r = 0.030,P = 0.762)之间存在相关性。与 HIV-阳性个体相比,HIV-阴性个体的 APOBEC3G 表达水平更高(P < 0.0001),包括来自同一个体的配对感染前和感染后样本(n = 13,P < 0.0001)。通过重测序和基因分型鉴定了 24 个单核苷酸多态性,包括 8 个新的多态性,位于 APOBEC3G 内。外显子 4 中的密码子改变突变(H186R)和 3' 外显子突变(rs35228531)与高病毒载量(P = 0.0097 和 P < 0.0001)和 CD4 T 细胞水平降低(P = 0.0081 和 P < 0.0001)相关。
这些数据表明,APOBEC3G 转录在感染 HIV-1 后迅速下调。在原发性感染期间,外周血单核细胞中的 APOBEC3G 表达水平与病毒载量或 CD4 T 细胞计数无关。APOBEC3G 的遗传变异可能显著影响 HIV-1 的早期发病机制,尽管其机制尚不清楚,仍需进一步研究。